SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
100 hedge funds and large institutions have $223M invested in Syros Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 34 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% less capital invested
Capital invested by funds: $276M → $223M (-$52.9M)
86% less call options, than puts
Call options by funds: $224K | Put options by funds: $1.55M
Holders
100
Holding in Top 10
1
Calls
$224K
Puts
$1.55M
Top Buyers
| 1 | +$4.24M | |
| 2 | +$1.34M | |
| 3 | +$1.06M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$941K |
| 5 |
ACM
Altium Capital Management
New York
|
+$874K |
Top Sellers
| 1 | -$5.45M | |
| 2 | -$1.93M | |
| 3 | -$1.11M | |
| 4 |
Millennium Management
New York
|
-$1.08M |
| 5 |
Morgan Stanley
New York
|
-$777K |